Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): A double-blind, randomised, phase 3 trial

P.M. Ellis, F.A. Shepherd, Michael Millward, F. Perrone, L. Seymour, G. Liu, S. Sun, B.C. Cho, A. Morabito, N.B. Leighl, M.R. Stockler, C.W. Lee, R. Wierzbicki, V. Cohen, N. Blais, R.S. Sangha, A.G. Favaretto, J.H. Kang, M.-S. Tsao, C.F. WilsonZ. Goldberg, K. Ding, G.D. Goss, P.A. Bradbury

    Research output: Contribution to journalArticle

    97 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1379-1388
    JournalThe Lancet Oncology
    Issue number12
    Publication statusPublished - 2014

    Cite this